Bendroflumethiazide and nadolol and Omalizumab Subcutaneous
Determining the interaction of Bendroflumethiazide and nadolol and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bendroflumethiazide / nadolol
Brand name: Corzide 40/5, Corzide 80/5, Corzide
Synonyms: Nadolol and Bendroflumethiazide
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bendroflumethiazide and nadolol-Ombitasvir, Paritaprevir, and Ritonavir
- Bendroflumethiazide and nadolol-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Bendroflumethiazide and nadolol-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Bendroflumethiazide and nadolol-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Bendroflumethiazide and nadolol-Omeclamox-Pak
- Bendroflumethiazide and nadolol-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-BeneFIX
- Omalizumab Subcutaneous-Benefix Intravenous
- Omalizumab Subcutaneous-Benemid
- Omalizumab Subcutaneous-BENGAY Ultra
- Omalizumab Subcutaneous-Benicar
- Omalizumab Subcutaneous-Benicar HCT